Dallas, TX, United States of America

Tissuegen, Inc.


USPTO Granted Patents = 5



Forward Citations = 8

Loading Chart...
Loading Chart...

14 inventors (with patents filed for the assignee):

goldMedal Brent B Crow (4 out of 6 patents)

silverMedal Kevin D Nelson (4 out of 10 patents)

bronzeMedal Jennifer Seifert (3 out of 3 patents)

4 Paul R Sood (3 out of 5 patents)

5 Nickolas B Griffin (3 out of 3 patents)

6 Alpeshkumar P Patel (3 out of 3 patents)

7 Paul A Hubbard (2 out of 2 patents)

8 William L D'Agostino (1 out of 10 patents)

9 Lev Drubetsky (1 out of 18 patents)

10 Alexander Naimagon (1 out of 14 patents)

11 Rui Avelar (1 out of 5 patents)

12 Paula J Taylor (1 out of 1 patent)

13 Ryszard Zarzycki (1 out of 5 patents)

14 Jeffrey Mendel Gross (1 out of 60 patents)

15 William L D'agostino (0 patent)


5 patents:

Tissuegen, Inc. is a biotechnology company focused on developing and commercializing regenerative medicine and drug delivery solutions. The company's patented technology allows for the controlled release of therapeutic agents within the body, enabling targeted drug delivery and tissue regeneration. With a commitment to advancing medical innovation, Tissuegen is dedicated to improving patient outcomes and quality of life.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

5 Patents

#369 in Dallas, TX

#3,323 in Texas

#51,493 in US

Dallas, TX (US)
Dallas, TX, United States of America
Forward Citations = 8

14 inventors:

Please report any incorrect information to [email protected]
Loading…